MicroRNA Market Size, Top Share, Demand

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global MicroRNA Market Size Analysis

Global MicroRNA Market Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Services
  1. By Value
  2. Profiling, Localization, & Quantification
    1. Profiling, Localization, & Quantification By Value
  3. miRNA cDNA Synthesis
    1. miRNA cDNA Synthesis By Value
  4. Isolation & Purification
    1. Isolation & Purification By Value
  5. Functional Analysis
    1. Functional Analysis By Value
  6. Others
    1. Others By Value
3. Products
  1. By Value
  2. Instruments
    1. Instruments By Value
  3. Real-Time PCR
    1. Real-Time PCR By Value
  4. Microarray
    1. Microarray By Value
  5. NGS
    1. NGS By Value
  6. Others
    1. Others By Value
4. Consumables
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cancer
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorder
  1. By Value
5. Cardiovascular Disease
  1. By Value
6. Neurological Disease
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Biotechnology & Pharmaceutical Companies
  1. By Value
3. Academic & Government Research Institutes
  1. By Value
4. Others
  1. By Value

North America Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Services
  1. By Value
  2. Profiling, Localization, & Quantification
    1. Profiling, Localization, & Quantification By Value
  3. miRNA cDNA Synthesis
    1. miRNA cDNA Synthesis By Value
  4. Isolation & Purification
    1. Isolation & Purification By Value
  5. Functional Analysis
    1. Functional Analysis By Value
  6. Others
    1. Others By Value
3. Products
  1. By Value
  2. Instruments
    1. Instruments By Value
  3. Real-Time PCR
    1. Real-Time PCR By Value
  4. Microarray
    1. Microarray By Value
  5. NGS
    1. NGS By Value
  6. Others
    1. Others By Value
4. Consumables
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cancer
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorder
  1. By Value
5. Cardiovascular Disease
  1. By Value
6. Neurological Disease
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Biotechnology & Pharmaceutical Companies
  1. By Value
3. Academic & Government Research Institutes
  1. By Value
4. Others
  1. By Value
U.S.
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Services
    1. By Value
    2. Profiling, Localization, & Quantification
      1. Profiling, Localization, & Quantification By Value
    3. miRNA cDNA Synthesis
      1. miRNA cDNA Synthesis By Value
    4. Isolation & Purification
      1. Isolation & Purification By Value
    5. Functional Analysis
      1. Functional Analysis By Value
    6. Others
      1. Others By Value
  3. Products
    1. By Value
    2. Instruments
      1. Instruments By Value
    3. Real-Time PCR
      1. Real-Time PCR By Value
    4. Microarray
      1. Microarray By Value
    5. NGS
      1. NGS By Value
    6. Others
      1. Others By Value
  4. Consumables
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cancer
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorder
    1. By Value
  5. Cardiovascular Disease
    1. By Value
  6. Neurological Disease
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Biotechnology & Pharmaceutical Companies
    1. By Value
  3. Academic & Government Research Institutes
    1. By Value
  4. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Services
  1. By Value
  2. Profiling, Localization, & Quantification
    1. Profiling, Localization, & Quantification By Value
  3. miRNA cDNA Synthesis
    1. miRNA cDNA Synthesis By Value
  4. Isolation & Purification
    1. Isolation & Purification By Value
  5. Functional Analysis
    1. Functional Analysis By Value
  6. Others
    1. Others By Value
3. Products
  1. By Value
  2. Instruments
    1. Instruments By Value
  3. Real-Time PCR
    1. Real-Time PCR By Value
  4. Microarray
    1. Microarray By Value
  5. NGS
    1. NGS By Value
  6. Others
    1. Others By Value
4. Consumables
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cancer
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorder
  1. By Value
5. Cardiovascular Disease
  1. By Value
6. Neurological Disease
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Biotechnology & Pharmaceutical Companies
  1. By Value
3. Academic & Government Research Institutes
  1. By Value
4. Others
  1. By Value
U.K.
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Services
    1. By Value
    2. Profiling, Localization, & Quantification
      1. Profiling, Localization, & Quantification By Value
    3. miRNA cDNA Synthesis
      1. miRNA cDNA Synthesis By Value
    4. Isolation & Purification
      1. Isolation & Purification By Value
    5. Functional Analysis
      1. Functional Analysis By Value
    6. Others
      1. Others By Value
  3. Products
    1. By Value
    2. Instruments
      1. Instruments By Value
    3. Real-Time PCR
      1. Real-Time PCR By Value
    4. Microarray
      1. Microarray By Value
    5. NGS
      1. NGS By Value
    6. Others
      1. Others By Value
  4. Consumables
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cancer
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorder
    1. By Value
  5. Cardiovascular Disease
    1. By Value
  6. Neurological Disease
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Biotechnology & Pharmaceutical Companies
    1. By Value
  3. Academic & Government Research Institutes
    1. By Value
  4. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Services
  1. By Value
  2. Profiling, Localization, & Quantification
    1. Profiling, Localization, & Quantification By Value
  3. miRNA cDNA Synthesis
    1. miRNA cDNA Synthesis By Value
  4. Isolation & Purification
    1. Isolation & Purification By Value
  5. Functional Analysis
    1. Functional Analysis By Value
  6. Others
    1. Others By Value
3. Products
  1. By Value
  2. Instruments
    1. Instruments By Value
  3. Real-Time PCR
    1. Real-Time PCR By Value
  4. Microarray
    1. Microarray By Value
  5. NGS
    1. NGS By Value
  6. Others
    1. Others By Value
4. Consumables
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cancer
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorder
  1. By Value
5. Cardiovascular Disease
  1. By Value
6. Neurological Disease
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Biotechnology & Pharmaceutical Companies
  1. By Value
3. Academic & Government Research Institutes
  1. By Value
4. Others
  1. By Value
China
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Services
    1. By Value
    2. Profiling, Localization, & Quantification
      1. Profiling, Localization, & Quantification By Value
    3. miRNA cDNA Synthesis
      1. miRNA cDNA Synthesis By Value
    4. Isolation & Purification
      1. Isolation & Purification By Value
    5. Functional Analysis
      1. Functional Analysis By Value
    6. Others
      1. Others By Value
  3. Products
    1. By Value
    2. Instruments
      1. Instruments By Value
    3. Real-Time PCR
      1. Real-Time PCR By Value
    4. Microarray
      1. Microarray By Value
    5. NGS
      1. NGS By Value
    6. Others
      1. Others By Value
  4. Consumables
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cancer
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorder
    1. By Value
  5. Cardiovascular Disease
    1. By Value
  6. Neurological Disease
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Biotechnology & Pharmaceutical Companies
    1. By Value
  3. Academic & Government Research Institutes
    1. By Value
  4. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Services
  1. By Value
  2. Profiling, Localization, & Quantification
    1. Profiling, Localization, & Quantification By Value
  3. miRNA cDNA Synthesis
    1. miRNA cDNA Synthesis By Value
  4. Isolation & Purification
    1. Isolation & Purification By Value
  5. Functional Analysis
    1. Functional Analysis By Value
  6. Others
    1. Others By Value
3. Products
  1. By Value
  2. Instruments
    1. Instruments By Value
  3. Real-Time PCR
    1. Real-Time PCR By Value
  4. Microarray
    1. Microarray By Value
  5. NGS
    1. NGS By Value
  6. Others
    1. Others By Value
4. Consumables
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cancer
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorder
  1. By Value
5. Cardiovascular Disease
  1. By Value
6. Neurological Disease
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Biotechnology & Pharmaceutical Companies
  1. By Value
3. Academic & Government Research Institutes
  1. By Value
4. Others
  1. By Value
UAE
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Services
    1. By Value
    2. Profiling, Localization, & Quantification
      1. Profiling, Localization, & Quantification By Value
    3. miRNA cDNA Synthesis
      1. miRNA cDNA Synthesis By Value
    4. Isolation & Purification
      1. Isolation & Purification By Value
    5. Functional Analysis
      1. Functional Analysis By Value
    6. Others
      1. Others By Value
  3. Products
    1. By Value
    2. Instruments
      1. Instruments By Value
    3. Real-Time PCR
      1. Real-Time PCR By Value
    4. Microarray
      1. Microarray By Value
    5. NGS
      1. NGS By Value
    6. Others
      1. Others By Value
  4. Consumables
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cancer
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorder
    1. By Value
  5. Cardiovascular Disease
    1. By Value
  6. Neurological Disease
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Biotechnology & Pharmaceutical Companies
    1. By Value
  3. Academic & Government Research Institutes
    1. By Value
  4. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Product & Services
1. Introduction
  1. Product & Services By Value
2. Services
  1. By Value
  2. Profiling, Localization, & Quantification
    1. Profiling, Localization, & Quantification By Value
  3. miRNA cDNA Synthesis
    1. miRNA cDNA Synthesis By Value
  4. Isolation & Purification
    1. Isolation & Purification By Value
  5. Functional Analysis
    1. Functional Analysis By Value
  6. Others
    1. Others By Value
3. Products
  1. By Value
  2. Instruments
    1. Instruments By Value
  3. Real-Time PCR
    1. Real-Time PCR By Value
  4. Microarray
    1. Microarray By Value
  5. NGS
    1. NGS By Value
  6. Others
    1. Others By Value
4. Consumables
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Cancer
  1. By Value
3. Infectious Diseases
  1. By Value
4. Immunological Disorder
  1. By Value
5. Cardiovascular Disease
  1. By Value
6. Neurological Disease
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Biotechnology & Pharmaceutical Companies
  1. By Value
3. Academic & Government Research Institutes
  1. By Value
4. Others
  1. By Value
Brazil
1. By Product & Services
  1. Introduction
    1. Product & Services By Value
  2. Services
    1. By Value
    2. Profiling, Localization, & Quantification
      1. Profiling, Localization, & Quantification By Value
    3. miRNA cDNA Synthesis
      1. miRNA cDNA Synthesis By Value
    4. Isolation & Purification
      1. Isolation & Purification By Value
    5. Functional Analysis
      1. Functional Analysis By Value
    6. Others
      1. Others By Value
  3. Products
    1. By Value
    2. Instruments
      1. Instruments By Value
    3. Real-Time PCR
      1. Real-Time PCR By Value
    4. Microarray
      1. Microarray By Value
    5. NGS
      1. NGS By Value
    6. Others
      1. Others By Value
  4. Consumables
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Cancer
    1. By Value
  3. Infectious Diseases
    1. By Value
  4. Immunological Disorder
    1. By Value
  5. Cardiovascular Disease
    1. By Value
  6. Neurological Disease
    1. By Value
  7. Others
    1. By Value
3. By End Use
  1. Introduction
    1. End Use By Value
  2. Biotechnology & Pharmaceutical Companies
    1. By Value
  3. Academic & Government Research Institutes
    1. By Value
  4. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

MicroRNA Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

BioGenex
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Bio-Techne Corporation
GeneCopoeia, Inc.
Abcam plc
Horizon Discovery Group plc.
InteRNA Technologies B.V.
LGC Limited
Merck KGaA
Mirna Therapeutics, Inc.
NanoString Technologies, Inc.
New England Biolabs
PerkinElmer, Inc.
QIAGEN
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
Synlogic, Inc.
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment